Literature DB >> 29773863

Low prevalence of argininosuccinate lyase deficiency among inherited urea cycle disorders in Korea.

Dahye Kim1, Jung Min Ko2, Yoon-Myung Kim1, Go Hun Seo1, Gu-Hwan Kim3, Beom Hee Lee4,5, Han-Wook Yoo6,7.   

Abstract

Argininosuccinic aciduria (ASA), which is considered to be the second most common urea cycle disorder (UCD), is caused by an argininosuccinate lyase deficiency and is biochemically characterized by elevation of argininosuccinic acid and arginine deficiency. In addition to hyperammonemia, other characteristic features of ASA include hepatic fibrosis, hypertension, neurocognitive deficiencies, and trichorrhexis nodosa. Herein, we retrospectively reviewed the clinical findings, biochemical profiles, and genotypic characteristics of five Korean patients with ASA, who showed typical phenotypes and biochemical findings of the disease. Molecular analysis of these patients revealed six novel ASL mutations. Next, we investigated the prevalence of all types of UCDs in Korea. Of note, over a two decade periods, ASA was only detected in 6.3% of patients with a UCD, which made it the fourth most common UCD in Korea. In comparison with Caucasians, in whom ASA is the second most common UCD, ASA is comparatively rare in East Asian populations, including Japanese and Koreans. These findings suggest the possibility of geographic variation in UCDs among ethnic groups.

Entities:  

Mesh:

Year:  2018        PMID: 29773863     DOI: 10.1038/s10038-018-0467-2

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  29 in total

1.  Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by newborn screening in Austria.

Authors:  S Mercimek-Mahmutoglu; D Moeslinger; J Häberle; K Engel; M Herle; M W Strobl; S Scheibenreiter; A Muehl; S Stöckler-Ipsiroglu
Journal:  Mol Genet Metab       Date:  2010-02-04       Impact factor: 4.797

2.  Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency.

Authors:  Toshihiko Mori; Kazushige Nagai; Michio Mori; Masayoshi Nagao; Masakatsu Imamura; Mikio Iijima; Keiko Kobayashi
Journal:  Pediatr Dev Pathol       Date:  2002-10-10

3.  Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene.

Authors:  Eva Trevisson; Leonardo Salviati; Maria Cristina Baldoin; Irene Toldo; Alberto Casarin; Sabrina Sacconi; Luca Cesaro; Giuseppe Basso; Alberto B Burlina
Journal:  Hum Mutat       Date:  2007-07       Impact factor: 4.878

4.  Argininosuccinic aciduria: clinical and biochemical phenotype findings in Malaysian children.

Authors:  Bee Chin Chen; Lock Hock Ngu; Md Yunus Zabedah
Journal:  Malays J Pathol       Date:  2010-12       Impact factor: 0.656

5.  Cross-sectional multicenter study of patients with urea cycle disorders in the United States.

Authors:  Mendel Tuchman; Brendan Lee; Uta Lichter-Konecki; Marshall L Summar; Marc Yudkoff; Stephen D Cederbaum; Douglas S Kerr; George A Diaz; Margaretta R Seashore; Hye-Seung Lee; Robert J McCarter; Jeffrey P Krischer; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2008-06-17       Impact factor: 4.797

6.  Screening newborns for inborn errors of metabolism by tandem mass spectrometry.

Authors:  Bridget Wilcken; Veronica Wiley; Judith Hammond; Kevin Carpenter
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

7.  Hereditary urea cycle diseases in Finland.

Authors:  Päivi Keskinen; Anna Siitonen; Matti Salo
Journal:  Acta Paediatr       Date:  2008-07-09       Impact factor: 2.299

8.  Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.

Authors:  L S Han; J Ye; W J Qiu; X L Gao; Y Wang; X F Gu
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.982

9.  Expanding the phenotype in argininosuccinic aciduria: need for new therapies.

Authors:  Julien Baruteau; Elisabeth Jameson; Andrew A Morris; Anupam Chakrapani; Saikat Santra; Suresh Vijay; Huriye Kocadag; Clare E Beesley; Stephanie Grunewald; Elaine Murphy; Maureen Cleary; Helen Mundy; Lara Abulhoul; Alexander Broomfield; Robin Lachmann; Yusof Rahman; Peter H Robinson; Lesley MacPherson; Katharine Foster; W Kling Chong; Deborah A Ridout; Kirsten McKay Bounford; Simon N Waddington; Philippa B Mills; Paul Gissen; James E Davison
Journal:  J Inherit Metab Dis       Date:  2017-03-01       Impact factor: 4.982

Review 10.  Argininosuccinic aciduria: from a monogenic to a complex disorder.

Authors:  Ayelet Erez
Journal:  Genet Med       Date:  2013-01-10       Impact factor: 8.822

View more
  3 in total

1.  Whole-Exome Sequencing Identified a Novel Compound Heterozygous Genotype in ASL in a Chinese Han Patient with Argininosuccinate Lyase Deficiency.

Authors:  Mei Zhao; Lingling Hou; Huajing Teng; Jinchen Li; Jiesi Wang; Kunlin Zhang; Lin Yang
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

Review 2.  Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology.

Authors:  Ming-Ling Chang; Sien-Sing Yang
Journal:  Cells       Date:  2019-11-12       Impact factor: 6.600

3.  Clinical and genetic analysis of five Chinese patients with urea cycle disorders.

Authors:  Zhenzhu Zheng; Yiming Lin; Weihua Lin; Lin Zhu; Mengyi Jiang; Wenjun Wang; Qingliu Fu
Journal:  Mol Genet Genomic Med       Date:  2020-05-15       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.